Andere Sprachen Nutra Pharma Corp.

Aktien

A14TB8

US67060U2087

NPHC

Markt geschlossen - OTC Markets Andere Börsenplätze 20:06:38 13.05.2024			% 5 Tage	% 1. Jan.
0,0001 ^USD	0,00 %		0,00 %	+9 900,00 %

22.03.	Nutra Pharma Corporation kündigt Änderungen im Management an	CI
22.03.	Nutra Pharma Corporation kündigt Wechsel des CEO an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Nutra Pharma Corp. Reaches Settlement with SEC	22.03.
Nutra Pharma Corporation Appoints Michael Flax as CFO	22.03.
Nutra Pharma Corporation Announces Management Changes	22.03.
Nutra Pharma Corporation Announces CEO Changes	22.03.
NUTRA PHARMA CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21.11.22
Nutra Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21.11.22
NUTRA PHARMA CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22.08.22
Nutra Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22.08.22
NUTRA PHARMA CORP : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	04.08.22
NUTRA PHARMA CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	20.05.22
Nutra Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	20.05.22
NUTRA PHARMA CORP Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-K)	15.04.22
Nutra Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	15.04.22
Nutra Pharma Corp. Auditor Raises 'Going Concern' Doubt	15.04.22
Nutra Pharma Announces First Manufacturing Agreement	23.03.22
Nutra Pharma Announces First Manufacturing Agreement	23.03.22
Nutra Pharma Expands Manufacturing Capabilities	17.03.22
Nutra Pharma Expands Manufacturing Capabilities	17.03.22
Nutra Pharma Letter to Shareholders	18.01.22
NUTRA PHARMA CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10.11.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Nutra Pharma Corp.

Aktien

A14TB8

US67060U2087

NPHC

Andere Sprachen

Filter